(Q37925938)

25 August 2017

1 reference

title

Gastric adenocarcinoma surgery and adjuvant therapy (English)

1 reference

25 August 2017

Gastric Adenocarcinoma Surgery and Adjuvant Therapy (English)

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

11 December 2024

1 reference

gastric adenocarcinoma

1 reference

Sameer H. Patel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21889029

11 December 2024

David A. Kooby

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21889029

11 December 2024

language of work or name

1 reference

1 October 2011

1 reference

25 August 2017

October 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21889029

full work available at URL

11 December 2024

https://api.elsevier.com/content/article/PII:S0039610911000739?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

https://api.elsevier.com/content/article/PII:S0039610911000739?httpAccept=text/plain

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Surgical Clinics of North America

11 December 2024

published in

1 reference

25 August 2017

volume

91

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

1039-1077

1 reference

Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach

25 August 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001964.PUB2

Global cancer statistics, 2002

1

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

11 December 2024

Cancer statistics, 2010

2

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification

11 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Is the prognosis for Japanese and German patients with gastric cancer really different?

11 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Etiopathogenesis of gastric cancer

11 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Pathology and molecular biology of gastric cancer

11 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Radical gastrectomy for cancer of the stomach

11 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Family history of cancer and stomach cancer risk

11 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families

11 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

11 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research

11 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Pathology and genetics of familial gastric cancer

11 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

E-cadherin germline mutations in familial gastric cancer.

11 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Familial gastric cancer: overview and guidelines for management

11 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Hereditary diffuse gastric cancer: diagnosis and management

11 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Effects of sex and racial/ethnic group on the pattern of gastric cancer localization

11 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Coexistence of acanthosis nigricans and the sign of Leser-Trélat in a patient with gastric adenocarcinoma: a case report and literature review

11 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis

11 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

A comparison of patterns of metastasis in gastric cancer by histologic type and age.

11 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Global patterns of cancer incidence and mortality rates and trends

11 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Early gastric cancer in Europe

11 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry

11 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period

11 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries

11 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Time trends of gastroesophageal reflux disease: a systematic review

11 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer

11 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer

11 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers

11 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases

11 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Screening for gastric cancer in Japan

11 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Double-contrast barium meal and upper gastrointestinal endoscopy. A comparative study

11 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Detection of early gastric cancer: misunderstanding the role of mass screening

11 December 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Usefulness of three-dimensional, multidetector row CT (virtual gastroscopy and multiplanar reconstruction) in the evaluation of gastric cancer: a comparison with conventional endoscopy, EUS, and histopathology.

11 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.

11 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer

11 December 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Lymph nodes and gastric cancer

11 December 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

MRI in staging advanced gastric cancer: is it useful compared with spiral CT?

11 December 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

MRI in staging of gastric cancer

11 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10

11 December 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy

11 December 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Imaging in local staging of gastric cancer: a systematic review

11 December 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Endoscopic ultrasonography for gastric cancer: does it influence treatment?

11 December 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Role of endoscopic ultrasound in staging upper gastrointestinal cancers

11 December 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Gastrointestinal imaging: endoscopic ultrasound

11 December 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Imaging in assessing lymph node status in gastric cancer

11 December 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer

11 December 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage

11 December 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database

11 December 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer

11 December 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Metastatic lymph node ratio in advanced gastric carcinoma: a better prognostic factor than number of metastatic lymph nodes?

11 December 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

The node ratio as prognostic factor after curative resection for gastric cancer

11 December 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer

11 December 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

11 December 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer

11 December 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Recurrence following curative resection for gastric carcinoma

11 December 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer

11 December 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Peritoneal lavage cytology findings as prognostic factor for gastric cancer

11 December 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Peritoneal lavage cytology in gastric cancer: an independent predictor of outcome

11 December 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Comparative studies on cytological and histological evaluations of disseminating peritoneal metastasis in gastric cancer

11 December 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Relationship between the cytologic characteristics of intraperitoneal free cancer cells and the prognosis in patients with gastric cancer

11 December 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Trypsinogen expression and early detection for peritoneal dissemination in gastric cancer

11 December 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Peritoneal wash cytology in gastric carcinoma. Prognostic significance and therapeutic consequences

11 December 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

The utility of pre-operative peritoneal lavage examination in serosa-invading gastric cancer patients

11 December 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

The Value of Peritoneal Cytology as a Preoperative Predictor in Patients With Gastric Carcinoma Undergoing a Curative Resection

11 December 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

7th Edition of the AJCC Cancer Staging Manual: Stomach

11 December 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

The role of the sentinel lymph node in gastrointestinal cancer

11 December 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Sentinel node mapping during laparoscopic distal gastrectomy for gastric cancer.

11 December 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Prediction of lymph nodes metastasis by sentinel node biopsy in gastric cancer

11 December 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Recent advances in sentinel node navigation for gastric cancer: a paradigm shift of surgical management

11 December 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Sentinel lymph node biopsy in gastric cancer: possible applications and limits

11 December 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Sentinel node mapping and skip metastases in patients with early gastric cancer.

11 December 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Factors associated with detection failure and false-negative sentinel node biopsy findings in gastric cancer: results of prospective single center trials

11 December 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

The accuracy of sentinel node mapping according to T stage in patients with gastric cancer

11 December 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer

11 December 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study

11 December 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

11 December 2024

Gastric Cancer

83

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study

11 December 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer.

11 December 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.

11 December 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Total or subtotal gastrectomy for gastric carcinoma? A study of quality of life

11 December 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach

11 December 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach

11 December 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Pouch vs. no pouch following total gastrectomy: meta-analysis and systematic review

11 December 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Does Roux-en Y reconstruction with jejunal pouch after total gastrectomy prevent complications of postgastrectomy?

11 December 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Gastrointestinal Quality of Life Index: development, validation and application of a new instrument

11 December 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Evaluation of extensive lymph node dissection for carcinoma of the stomach

11 December 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Should systematic lymph node dissection be recommended for gastric cancer?

11 December 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Extended lymph-node dissection for gastric cancer

11 December 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial

11 December 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial

11 December 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma

11 December 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Nodal dissection for patients with gastric cancer: a randomised controlled trial

11 December 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer

11 December 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

The extent of lymph node dissection for gastric cancer: A critical appraisal

11 December 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Prognostic Impact of Splenectomy on Gastric Cancer: Results of the Korean Gastric Cancer Study Group

11 December 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Critical evaluation of prophylactic splenectomy in total gastrectomy for the stomach cancer

11 December 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Indication of splenectomy for gastric carcinoma involving the proximal part of the stomach

11 December 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients

11 December 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group

11 December 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Is there a benefit of pancreaticosplenectomy with gastrectomy for advanced gastric cancer?

11 December 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer

11 December 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma

11 December 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Laparoscopic Surgery for Gastric Cancer: A Collective Review with Meta-Analysis of Randomized Trials

11 December 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Laparoscopic D2 lymph node dissection for advanced gastric cancer located in the middle or lower third portion of the stomach

11 December 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Laparoscopic gastrectomy for gastric cancer: experience with more than 600 cases

11 December 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Inspection of safety and accuracy of D2 lymph node dissection in laparoscopy-assisted distal gastrectomy

11 December 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery

11 December 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial).

11 December 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial

11 December 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Endoscopic mucosal resection and endoscopic submucosal dissection in esophageal and gastric cancers

11 December 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Endoscopic resection of early gastric cancer

11 December 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Endoscopic mucosal resection for treatment of early gastric cancer

11 December 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Endoscopic mucosal resection (EMR): results and prognostic factors in 21 patients

11 December 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Outcome of endoscopic mucosal resection for early gastric cancer: review of the Japanese literature

11 December 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Endoscopic mucosal resection with a ligation device for early gastric cancer and precancerous lesions: comparison of its therapeutic efficacy with surgical resection

11 December 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

A new technique for endoscopic mucosal resection with an insulated-tip electrosurgical knife improves the completeness of resection of intramucosal gastric neoplasms

11 December 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Successful en-bloc resection of large superficial tumors in the stomach and colon using sodium hyaluronate and small-caliber-tip transparent hood

11 December 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Endoscopic submucosal dissection in gastric neoplasia - experience from a European center

11 December 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Predicting lymph node status in early gastric cancer

11 December 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract

11 December 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989

11 December 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

NOTES: The question for minimal resection and sentinel node in early gastric cancer.

11 December 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Hybrid natural orifice transluminal endoscopic surgery: endoscopic full-thickness resection of early gastric cancer and laparoscopic regional lymph node dissection--14 human cases

11 December 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Endoscopic full-thickness resection with laparoscopic assistance as hybrid NOTES for gastric submucosal tumor

11 December 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Gastric lymphatic mapping for sentinel node biopsy by natural orifice transluminal endoscopic surgery (NOTES).

11 December 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Robot-assisted gastrectomy with lymph node dissection for gastric cancer: lessons learned from an initial 100 consecutive procedures.

11 December 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501

11 December 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Treatment options for surgically resectable gastric cancer

11 December 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer

11 December 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis

11 December 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

11 December 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial

11 December 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Clinical significance of preoperative regional intra-arterial infusion chemotherapy for advanced gastric cancer

11 December 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Japanese Journal of Cancer and Chemotherapy

11 December 2024

154

27

1521

Kobayashi

2000

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial

11 December 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Japanese Journal of Cancer and Chemotherapy

11 December 2024

157

21

2253

Masuyama

1994

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Neoadjuvant chemotherapy for high-grade advanced gastric cancer

11 December 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Japanese Journal of Cancer and Chemotherapy

11 December 2024

159

9

1427

Nishioka

1982

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant and neoadjuvant approaches in gastric cancer

11 December 2024

161

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients

11 December 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer

11 December 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.

11 December 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Preoperative versus postoperative chemoradiotherapy for rectal cancer

11 December 2024

165

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

11 December 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival

11 December 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma

11 December 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response

11 December 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Optimal locoregional treatment in gastric cancer

11 December 2024

170

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant therapy in gastric cancer

11 December 2024

171

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma

11 December 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials

11 December 2024

173

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Chemotherapy in gastric cancer: a review and updated meta-analysis

11 December 2024

174

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

11 December 2024

175

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up

11 December 2024

176

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

11 December 2024

177

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

The survival impact of the intergroup 0116 trial on patients with gastric cancer

11 December 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant Therapy for Resected Gastric Cancer—Rapid, Yet Incomplete Adoption Following Results of Intergroup 0116 Trial

11 December 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Surgical treatment for peritoneal carcinomatosis from gastric cancer

11 December 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay

11 December 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer

11 December 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Distribution of free cancer cells in the abdominal cavity suggests limitations of bursectomy as an essential component of radical surgery for gastric carcinoma

11 December 2024

184

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy

11 December 2024

185

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer

11 December 2024

186

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer.

11 December 2024

187

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?

11 December 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Palliative gastrectomy and chemotherapy for stage IV gastric cancer

11 December 2024

189

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: A retrospective analysis

11 December 2024

190

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group

11 December 2024

192

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A veterans administration surgical oncology group report

11 December 2024

193

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275).

11 December 2024

194

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant treatments following curative resection for gastric cancer. The Italian Gastrointestinal Tumor Study Group

11 December 2024

195

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.

11 December 2024

196

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10-year follow-up

11 December 2024

197

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer

11 December 2024

198

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer

11 December 2024

199

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Positive results of adjuvant mitomycin-C in resected gastric cancer: a randomised trial on 134 patients

11 December 2024

200

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer

11 December 2024

201

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study

11 December 2024

202

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up

11 December 2024

203

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group

11 December 2024

204

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group

11 December 2024

205

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.

11 December 2024

206

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer

11 December 2024

207

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801).

11 December 2024

208

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.

11 December 2024

209

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer

11 December 2024

210

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)

11 December 2024

211

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

11 December 2024

212

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

11 December 2024

213

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial

11 December 2024

214

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials

11 December 2024

215

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

11 December 2024

216

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses

11 December 2024

217

1 reference

https://api.crossref.org/works/10.1016/J.SUC.2011.06.009

11 December 2024

Identifiers

1 reference

25 August 2017

1 reference